Showing results (521-530 of 914) with videos related to

Sort By:
Pageof 92
Biorxiv : the Preprint Server for Biology|October 4, 2023
<i>ESR1</i> fusion proteins invoke breast cancer subtype-dependent enrichment of ligand independent pro-oncogenic signatures and phenotypesMegan E Yates, Zheqi Li, Yiting Li, et al.
Environmental Geochemistry and Health|June 26, 2020
Chronic kidney disease of unknown origin is associated with environmental urbanisation in Belfast, UKJennifer M McKinley, Ute Mueller, Peter M Atkinson, et al.
Plos Neglected Tropical Diseases|October 8, 2016
The Sero-epidemiology of Coxiella burnetii in Humans and Cattle, Western Kenya: Evidence from a Cross-Sectional StudyNicola A Wardrop, Lian F Thomas, Elizabeth A J Cook, et al.
Parasites & Vectors|July 26, 2012
Impact of anthropogenic and natural environmental changes on Echinococcus transmission in Ningxia Hui Autonomous Region, the People's Republic of ChinaYu Rong Yang, Archie C A Clements, Darren J Gray, et al.
Plant Disease|February 17, 2019
Region and Field Level Distributions of Aster Yellows Phytoplasma in Small Grain CropsC R Hollingsworth, L M Atkinson, D A Samac, et al.
Diabetologia|December 17, 2004
High frequency of abnormal glucose tolerance in DQA1*0102/DQB1*0602 relatives identified as part of the Diabetes Prevention Trial--Type 1 DiabetesC J Greenbaum, G Eisenbarth, M Atkinson, et al.
Human Vaccines & Immunotherapeutics|February 28, 2018
Immunization and technology among newcomers: A needs assessment survey for a vaccine-tracking appMichelle Paradis, Katherine M Atkinson, Charles Hui, et al.
Oncology Nursing Forum|August 20, 2016
The Association Between Patient-Reported and Objective Oral Anticancer Medication Adherence Measures: A Systematic Review
Thomas M Atkinson, Vivian M Rodríguez, Mallorie Gordon, et al.
Clinical and Experimental Immunology|August 8, 2007
Extremes of L-ficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 geneM Cedzynski, L Nuytinck, A P M Atkinson, et al.
Molecular Pharmaceutics|March 20, 2014
Tumor-targeted prodrug ICT2588 demonstrates therapeutic activity against solid tumors and reduced potential for cardiovascular toxicityJason H Gill, Paul M Loadman, Steven D Shnyder, et al.
Pageof 92